nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentobarbital—CYP2A6—Prednisolone—multiple sclerosis	0.143	0.238	CbGbCtD
Pentobarbital—CYP2A6—Dexamethasone—multiple sclerosis	0.0842	0.141	CbGbCtD
Pentobarbital—CYP3A4—Fingolimod—multiple sclerosis	0.069	0.115	CbGbCtD
Pentobarbital—CYP2C19—Prednisone—multiple sclerosis	0.0558	0.0932	CbGbCtD
Pentobarbital—CYP3A4—Methylprednisolone—multiple sclerosis	0.0445	0.0743	CbGbCtD
Pentobarbital—CYP2C19—Dexamethasone—multiple sclerosis	0.0348	0.0582	CbGbCtD
Pentobarbital—CYP3A4—Triamcinolone—multiple sclerosis	0.0337	0.0563	CbGbCtD
Pentobarbital—CYP3A4—Mitoxantrone—multiple sclerosis	0.0325	0.0542	CbGbCtD
Pentobarbital—CYP3A4—Betamethasone—multiple sclerosis	0.0289	0.0483	CbGbCtD
Pentobarbital—CYP3A4—Prednisolone—multiple sclerosis	0.0285	0.0477	CbGbCtD
Pentobarbital—CYP3A4—Prednisone—multiple sclerosis	0.027	0.045	CbGbCtD
Pentobarbital—CYP3A4—Dexamethasone—multiple sclerosis	0.0168	0.0281	CbGbCtD
Pentobarbital—Anaemia megaloblastic—Azathioprine—multiple sclerosis	0.0142	0.0869	CcSEcCtD
Pentobarbital—CHRNA4—peripheral nervous system—multiple sclerosis	0.011	0.0507	CbGeAlD
Pentobarbital—GRIK2—nerve—multiple sclerosis	0.0107	0.0491	CbGeAlD
Pentobarbital—Liver injury—Fingolimod—multiple sclerosis	0.00865	0.0528	CcSEcCtD
Pentobarbital—CHRNA4—nerve—multiple sclerosis	0.00856	0.0395	CbGeAlD
Pentobarbital—Anaemia megaloblastic—Methotrexate—multiple sclerosis	0.00574	0.035	CcSEcCtD
Pentobarbital—GRIA2—brainstem—multiple sclerosis	0.00506	0.0234	CbGeAlD
Pentobarbital—GABRA6—brainstem—multiple sclerosis	0.00489	0.0226	CbGeAlD
Pentobarbital—GRIK2—brainstem—multiple sclerosis	0.00457	0.0211	CbGeAlD
Pentobarbital—GRIK2—retina—multiple sclerosis	0.00441	0.0204	CbGeAlD
Pentobarbital—Injection site reaction—Cladribine—multiple sclerosis	0.0041	0.025	CcSEcCtD
Pentobarbital—Liver injury—Azathioprine—multiple sclerosis	0.00399	0.0243	CcSEcCtD
Pentobarbital—Depressed level of consciousness—Cladribine—multiple sclerosis	0.00399	0.0243	CcSEcCtD
Pentobarbital—Bradycardia—Fingolimod—multiple sclerosis	0.00372	0.0227	CcSEcCtD
Pentobarbital—CHRNA4—brainstem—multiple sclerosis	0.00368	0.017	CbGeAlD
Pentobarbital—GABRB2—brainstem—multiple sclerosis	0.0036	0.0166	CbGeAlD
Pentobarbital—CHRNA7—retina—multiple sclerosis	0.00359	0.0166	CbGeAlD
Pentobarbital—Hepatocellular injury—Azathioprine—multiple sclerosis	0.00336	0.0205	CcSEcCtD
Pentobarbital—GABRA2—brainstem—multiple sclerosis	0.00329	0.0152	CbGeAlD
Pentobarbital—GRIA2—midbrain—multiple sclerosis	0.00323	0.0149	CbGeAlD
Pentobarbital—GRIK2—medulla oblongata—multiple sclerosis	0.00319	0.0147	CbGeAlD
Pentobarbital—GABRA1—brainstem—multiple sclerosis	0.00318	0.0147	CbGeAlD
Pentobarbital—GRIA2—spinal cord—multiple sclerosis	0.00315	0.0145	CbGeAlD
Pentobarbital—GRIK2—midbrain—multiple sclerosis	0.00291	0.0134	CbGeAlD
Pentobarbital—GRIK2—spinal cord—multiple sclerosis	0.00284	0.0131	CbGeAlD
Pentobarbital—Ataxia—Cladribine—multiple sclerosis	0.00282	0.0172	CcSEcCtD
Pentobarbital—GRIA2—nervous system—multiple sclerosis	0.00265	0.0122	CbGeAlD
Pentobarbital—GABRA6—nervous system—multiple sclerosis	0.00256	0.0118	CbGeAlD
Pentobarbital—GRIA2—central nervous system—multiple sclerosis	0.00255	0.0118	CbGeAlD
Pentobarbital—GABRB2—medulla oblongata—multiple sclerosis	0.00251	0.0116	CbGeAlD
Pentobarbital—GABRG2—medulla oblongata—multiple sclerosis	0.00251	0.0116	CbGeAlD
Pentobarbital—GRIA2—cerebellum—multiple sclerosis	0.0025	0.0115	CbGeAlD
Pentobarbital—GABRA5—nervous system—multiple sclerosis	0.00249	0.0115	CbGeAlD
Pentobarbital—GABRA6—central nervous system—multiple sclerosis	0.00247	0.0114	CbGeAlD
Pentobarbital—Hypotension—Fingolimod—multiple sclerosis	0.00243	0.0148	CcSEcCtD
Pentobarbital—CHRFAM7A—nervous system—multiple sclerosis	0.00242	0.0111	CbGeAlD
Pentobarbital—GABRA6—cerebellum—multiple sclerosis	0.00241	0.0111	CbGeAlD
Pentobarbital—GRIK2—nervous system—multiple sclerosis	0.0024	0.0111	CbGeAlD
Pentobarbital—GABRA5—central nervous system—multiple sclerosis	0.00239	0.011	CbGeAlD
Pentobarbital—CHRNA4—midbrain—multiple sclerosis	0.00234	0.0108	CbGeAlD
Pentobarbital—CHRFAM7A—central nervous system—multiple sclerosis	0.00233	0.0107	CbGeAlD
Pentobarbital—GABRA3—nervous system—multiple sclerosis	0.00231	0.0107	CbGeAlD
Pentobarbital—GRIK2—central nervous system—multiple sclerosis	0.00231	0.0106	CbGeAlD
Pentobarbital—GABRB2—midbrain—multiple sclerosis	0.00229	0.0106	CbGeAlD
Pentobarbital—GABRG2—midbrain—multiple sclerosis	0.00229	0.0106	CbGeAlD
Pentobarbital—CHRNA4—spinal cord—multiple sclerosis	0.00229	0.0105	CbGeAlD
Pentobarbital—GABRA4—nervous system—multiple sclerosis	0.00226	0.0104	CbGeAlD
Pentobarbital—GRIK2—cerebellum—multiple sclerosis	0.00225	0.0104	CbGeAlD
Pentobarbital—GABRB2—spinal cord—multiple sclerosis	0.00224	0.0103	CbGeAlD
Pentobarbital—GABRG2—spinal cord—multiple sclerosis	0.00224	0.0103	CbGeAlD
Pentobarbital—GABRA3—central nervous system—multiple sclerosis	0.00223	0.0103	CbGeAlD
Pentobarbital—GABRA1—medulla oblongata—multiple sclerosis	0.00222	0.0102	CbGeAlD
Pentobarbital—GABRA4—central nervous system—multiple sclerosis	0.00217	0.01	CbGeAlD
Pentobarbital—Hypoxia—Methotrexate—multiple sclerosis	0.00213	0.013	CcSEcCtD
Pentobarbital—GABRA4—cerebellum—multiple sclerosis	0.00212	0.00979	CbGeAlD
Pentobarbital—GRIA2—brain—multiple sclerosis	0.00203	0.00935	CbGeAlD
Pentobarbital—GABRA1—midbrain—multiple sclerosis	0.00203	0.00935	CbGeAlD
Pentobarbital—GABRA1—spinal cord—multiple sclerosis	0.00198	0.00912	CbGeAlD
Pentobarbital—GABRA6—brain—multiple sclerosis	0.00196	0.00904	CbGeAlD
Pentobarbital—CHRNA7—nervous system—multiple sclerosis	0.00195	0.009	CbGeAlD
Pentobarbital—GABRB3—medulla oblongata—multiple sclerosis	0.00193	0.00889	CbGeAlD
Pentobarbital—CHRNA4—nervous system—multiple sclerosis	0.00193	0.00888	CbGeAlD
Pentobarbital—GABRA5—brain—multiple sclerosis	0.0019	0.00877	CbGeAlD
Pentobarbital—GABRB2—nervous system—multiple sclerosis	0.00189	0.0087	CbGeAlD
Pentobarbital—GABRG2—nervous system—multiple sclerosis	0.00189	0.0087	CbGeAlD
Pentobarbital—CHRNA7—central nervous system—multiple sclerosis	0.00188	0.00867	CbGeAlD
Pentobarbital—CHRNA4—central nervous system—multiple sclerosis	0.00185	0.00855	CbGeAlD
Pentobarbital—CHRFAM7A—brain—multiple sclerosis	0.00185	0.00852	CbGeAlD
Pentobarbital—CYP2A6—cerebellum—multiple sclerosis	0.00184	0.00847	CbGeAlD
Pentobarbital—GRIK2—brain—multiple sclerosis	0.00183	0.00845	CbGeAlD
Pentobarbital—GABRB2—central nervous system—multiple sclerosis	0.00182	0.00838	CbGeAlD
Pentobarbital—GABRG2—central nervous system—multiple sclerosis	0.00182	0.00838	CbGeAlD
Pentobarbital—CHRNA4—cerebellum—multiple sclerosis	0.00181	0.00836	CbGeAlD
Pentobarbital—GABRG2—cerebellum—multiple sclerosis	0.00178	0.00819	CbGeAlD
Pentobarbital—GABRB2—cerebellum—multiple sclerosis	0.00178	0.00819	CbGeAlD
Pentobarbital—GABRA3—brain—multiple sclerosis	0.00177	0.00816	CbGeAlD
Pentobarbital—GABRB3—midbrain—multiple sclerosis	0.00176	0.00813	CbGeAlD
Pentobarbital—GABRA4—brain—multiple sclerosis	0.00172	0.00795	CbGeAlD
Pentobarbital—GABRA2—nervous system—multiple sclerosis	0.00172	0.00795	CbGeAlD
Pentobarbital—GABRB3—spinal cord—multiple sclerosis	0.00172	0.00793	CbGeAlD
Pentobarbital—Dizziness—Fingolimod—multiple sclerosis	0.00172	0.0105	CcSEcCtD
Pentobarbital—GABRA1—nervous system—multiple sclerosis	0.00167	0.00768	CbGeAlD
Pentobarbital—GABRA2—central nervous system—multiple sclerosis	0.00166	0.00766	CbGeAlD
Pentobarbital—Headache—Fingolimod—multiple sclerosis	0.00163	0.00993	CcSEcCtD
Pentobarbital—GABRA2—cerebellum—multiple sclerosis	0.00162	0.00748	CbGeAlD
Pentobarbital—GABRA1—central nervous system—multiple sclerosis	0.0016	0.0074	CbGeAlD
Pentobarbital—Apnoea—Methotrexate—multiple sclerosis	0.00159	0.00973	CcSEcCtD
Pentobarbital—GABRA1—cerebellum—multiple sclerosis	0.00157	0.00723	CbGeAlD
Pentobarbital—Anxiety—Cladribine—multiple sclerosis	0.00153	0.00934	CcSEcCtD
Pentobarbital—CHRNA7—brain—multiple sclerosis	0.00149	0.00688	CbGeAlD
Pentobarbital—CYP2A6—brain—multiple sclerosis	0.00149	0.00688	CbGeAlD
Pentobarbital—Confusional state—Cladribine—multiple sclerosis	0.00148	0.00906	CcSEcCtD
Pentobarbital—CHRNA4—brain—multiple sclerosis	0.00147	0.00679	CbGeAlD
Pentobarbital—GABRB3—nervous system—multiple sclerosis	0.00145	0.00668	CbGeAlD
Pentobarbital—GABRB2—brain—multiple sclerosis	0.00144	0.00665	CbGeAlD
Pentobarbital—GABRG2—brain—multiple sclerosis	0.00144	0.00665	CbGeAlD
Pentobarbital—Hyperkinesia—Prednisone—multiple sclerosis	0.00141	0.00861	CcSEcCtD
Pentobarbital—GABRB3—central nervous system—multiple sclerosis	0.00139	0.00643	CbGeAlD
Pentobarbital—Bradycardia—Mitoxantrone—multiple sclerosis	0.00139	0.00846	CcSEcCtD
Pentobarbital—Respiratory failure—Methotrexate—multiple sclerosis	0.00138	0.0084	CcSEcCtD
Pentobarbital—Hypotension—Cladribine—multiple sclerosis	0.00138	0.0084	CcSEcCtD
Pentobarbital—GABRB3—cerebellum—multiple sclerosis	0.00136	0.00629	CbGeAlD
Pentobarbital—GABRA2—brain—multiple sclerosis	0.00132	0.00608	CbGeAlD
Pentobarbital—Somnolence—Cladribine—multiple sclerosis	0.00131	0.00799	CcSEcCtD
Pentobarbital—Depressed level of consciousness—Methotrexate—multiple sclerosis	0.00131	0.00797	CcSEcCtD
Pentobarbital—GABRA1—brain—multiple sclerosis	0.00127	0.00587	CbGeAlD
Pentobarbital—Constipation—Cladribine—multiple sclerosis	0.00126	0.00768	CcSEcCtD
Pentobarbital—Feeling abnormal—Cladribine—multiple sclerosis	0.00121	0.00741	CcSEcCtD
Pentobarbital—Body temperature increased—Cladribine—multiple sclerosis	0.00116	0.0071	CcSEcCtD
Pentobarbital—Bradycardia—Prednisolone—multiple sclerosis	0.00114	0.00694	CcSEcCtD
Pentobarbital—Hypotension—Azathioprine—multiple sclerosis	0.00112	0.00683	CcSEcCtD
Pentobarbital—GABRB3—brain—multiple sclerosis	0.00111	0.00511	CbGeAlD
Pentobarbital—Hypersensitivity—Cladribine—multiple sclerosis	0.00108	0.00662	CcSEcCtD
Pentobarbital—Bradycardia—Triamcinolone—multiple sclerosis	0.00105	0.00639	CcSEcCtD
Pentobarbital—Bradycardia—Methylprednisolone—multiple sclerosis	0.00104	0.00637	CcSEcCtD
Pentobarbital—Dermatitis exfoliative—Methotrexate—multiple sclerosis	0.00104	0.00635	CcSEcCtD
Pentobarbital—Hallucination—Methylprednisolone—multiple sclerosis	0.00102	0.00623	CcSEcCtD
Pentobarbital—Anxiety—Mitoxantrone—multiple sclerosis	0.00101	0.00614	CcSEcCtD
Pentobarbital—Feeling abnormal—Azathioprine—multiple sclerosis	0.000987	0.00602	CcSEcCtD
Pentobarbital—Confusional state—Mitoxantrone—multiple sclerosis	0.000976	0.00596	CcSEcCtD
Pentobarbital—Dizziness—Cladribine—multiple sclerosis	0.000974	0.00594	CcSEcCtD
Pentobarbital—Shock—Mitoxantrone—multiple sclerosis	0.000952	0.00581	CcSEcCtD
Pentobarbital—Bradycardia—Betamethasone—multiple sclerosis	0.000949	0.00579	CcSEcCtD
Pentobarbital—Bradycardia—Dexamethasone—multiple sclerosis	0.000949	0.00579	CcSEcCtD
Pentobarbital—Body temperature increased—Azathioprine—multiple sclerosis	0.000947	0.00578	CcSEcCtD
Pentobarbital—Vomiting—Cladribine—multiple sclerosis	0.000936	0.00571	CcSEcCtD
Pentobarbital—Rash—Cladribine—multiple sclerosis	0.000928	0.00567	CcSEcCtD
Pentobarbital—Hallucination—Betamethasone—multiple sclerosis	0.000928	0.00566	CcSEcCtD
Pentobarbital—Hallucination—Dexamethasone—multiple sclerosis	0.000928	0.00566	CcSEcCtD
Pentobarbital—Dermatitis—Cladribine—multiple sclerosis	0.000928	0.00566	CcSEcCtD
Pentobarbital—Ataxia—Methotrexate—multiple sclerosis	0.000923	0.00563	CcSEcCtD
Pentobarbital—Headache—Cladribine—multiple sclerosis	0.000922	0.00563	CcSEcCtD
Pentobarbital—Hypotension—Mitoxantrone—multiple sclerosis	0.000904	0.00552	CcSEcCtD
Pentobarbital—Angioedema—Prednisolone—multiple sclerosis	0.000889	0.00543	CcSEcCtD
Pentobarbital—Hypersensitivity—Azathioprine—multiple sclerosis	0.000882	0.00538	CcSEcCtD
Pentobarbital—Nausea—Cladribine—multiple sclerosis	0.000875	0.00534	CcSEcCtD
Pentobarbital—Syncope—Prednisolone—multiple sclerosis	0.000873	0.00532	CcSEcCtD
Pentobarbital—Somnolence—Mitoxantrone—multiple sclerosis	0.00086	0.00525	CcSEcCtD
Pentobarbital—Loss of consciousness—Prednisolone—multiple sclerosis	0.000855	0.00522	CcSEcCtD
Pentobarbital—Constipation—Mitoxantrone—multiple sclerosis	0.000828	0.00505	CcSEcCtD
Pentobarbital—Bradycardia—Prednisone—multiple sclerosis	0.000827	0.00505	CcSEcCtD
Pentobarbital—Angioedema—Triamcinolone—multiple sclerosis	0.000818	0.00499	CcSEcCtD
Pentobarbital—Angioedema—Methylprednisolone—multiple sclerosis	0.000816	0.00498	CcSEcCtD
Pentobarbital—Hallucination—Prednisone—multiple sclerosis	0.000808	0.00493	CcSEcCtD
Pentobarbital—Syncope—Triamcinolone—multiple sclerosis	0.000802	0.0049	CcSEcCtD
Pentobarbital—Syncope—Methylprednisolone—multiple sclerosis	0.000801	0.00489	CcSEcCtD
Pentobarbital—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.000798	0.00487	CcSEcCtD
Pentobarbital—Dizziness—Azathioprine—multiple sclerosis	0.000792	0.00483	CcSEcCtD
Pentobarbital—Loss of consciousness—Triamcinolone—multiple sclerosis	0.000786	0.0048	CcSEcCtD
Pentobarbital—Loss of consciousness—Methylprednisolone—multiple sclerosis	0.000785	0.00479	CcSEcCtD
Pentobarbital—Shock—Prednisolone—multiple sclerosis	0.000781	0.00477	CcSEcCtD
Pentobarbital—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000765	0.00467	CcSEcCtD
Pentobarbital—Vomiting—Azathioprine—multiple sclerosis	0.000761	0.00465	CcSEcCtD
Pentobarbital—Anxiety—Methylprednisolone—multiple sclerosis	0.000757	0.00462	CcSEcCtD
Pentobarbital—Rash—Azathioprine—multiple sclerosis	0.000755	0.00461	CcSEcCtD
Pentobarbital—Dermatitis—Azathioprine—multiple sclerosis	0.000754	0.0046	CcSEcCtD
Pentobarbital—Headache—Azathioprine—multiple sclerosis	0.00075	0.00458	CcSEcCtD
Pentobarbital—Angioedema—Betamethasone—multiple sclerosis	0.000742	0.00453	CcSEcCtD
Pentobarbital—Angioedema—Dexamethasone—multiple sclerosis	0.000742	0.00453	CcSEcCtD
Pentobarbital—CYP3A4—nervous system—multiple sclerosis	0.000742	0.00342	CbGeAlD
Pentobarbital—Confusional state—Methylprednisolone—multiple sclerosis	0.000735	0.00448	CcSEcCtD
Pentobarbital—Syncope—Dexamethasone—multiple sclerosis	0.000728	0.00444	CcSEcCtD
Pentobarbital—Syncope—Betamethasone—multiple sclerosis	0.000728	0.00444	CcSEcCtD
Pentobarbital—Shock—Triamcinolone—multiple sclerosis	0.000718	0.00438	CcSEcCtD
Pentobarbital—Shock—Methylprednisolone—multiple sclerosis	0.000717	0.00437	CcSEcCtD
Pentobarbital—CYP3A4—central nervous system—multiple sclerosis	0.000714	0.00329	CbGeAlD
Pentobarbital—Loss of consciousness—Dexamethasone—multiple sclerosis	0.000714	0.00435	CcSEcCtD
Pentobarbital—Loss of consciousness—Betamethasone—multiple sclerosis	0.000714	0.00435	CcSEcCtD
Pentobarbital—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000713	0.00435	CcSEcCtD
Pentobarbital—Nausea—Azathioprine—multiple sclerosis	0.000711	0.00434	CcSEcCtD
Pentobarbital—CHRNA7—SIDS Susceptibility Pathways—PLP1—multiple sclerosis	0.000705	0.0338	CbGpPWpGaD
Pentobarbital—Anxiety—Betamethasone—multiple sclerosis	0.000689	0.0042	CcSEcCtD
Pentobarbital—Anxiety—Dexamethasone—multiple sclerosis	0.000689	0.0042	CcSEcCtD
Pentobarbital—Hypotension—Methylprednisolone—multiple sclerosis	0.000681	0.00416	CcSEcCtD
Pentobarbital—Feeling abnormal—Prednisolone—multiple sclerosis	0.000654	0.00399	CcSEcCtD
Pentobarbital—Shock—Betamethasone—multiple sclerosis	0.000652	0.00398	CcSEcCtD
Pentobarbital—Shock—Dexamethasone—multiple sclerosis	0.000652	0.00398	CcSEcCtD
Pentobarbital—Agitation—Prednisone—multiple sclerosis	0.00065	0.00397	CcSEcCtD
Pentobarbital—Angioedema—Prednisone—multiple sclerosis	0.000646	0.00394	CcSEcCtD
Pentobarbital—Syncope—Prednisone—multiple sclerosis	0.000634	0.00387	CcSEcCtD
Pentobarbital—Loss of consciousness—Prednisone—multiple sclerosis	0.000621	0.00379	CcSEcCtD
Pentobarbital—Hypotension—Betamethasone—multiple sclerosis	0.000619	0.00378	CcSEcCtD
Pentobarbital—Hypotension—Dexamethasone—multiple sclerosis	0.000619	0.00378	CcSEcCtD
Pentobarbital—Vomiting—Mitoxantrone—multiple sclerosis	0.000615	0.00376	CcSEcCtD
Pentobarbital—Rash—Mitoxantrone—multiple sclerosis	0.00061	0.00372	CcSEcCtD
Pentobarbital—Dermatitis—Mitoxantrone—multiple sclerosis	0.00061	0.00372	CcSEcCtD
Pentobarbital—Headache—Mitoxantrone—multiple sclerosis	0.000606	0.0037	CcSEcCtD
Pentobarbital—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000602	0.00367	CcSEcCtD
Pentobarbital—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.0006	0.00366	CcSEcCtD
Pentobarbital—Anxiety—Prednisone—multiple sclerosis	0.0006	0.00366	CcSEcCtD
Pentobarbital—Hypersensitivity—Prednisolone—multiple sclerosis	0.000585	0.00357	CcSEcCtD
Pentobarbital—Body temperature increased—Triamcinolone—multiple sclerosis	0.000577	0.00352	CcSEcCtD
Pentobarbital—CHRNA4—SIDS Susceptibility Pathways—PLP1—multiple sclerosis	0.000575	0.0276	CbGpPWpGaD
Pentobarbital—Nausea—Mitoxantrone—multiple sclerosis	0.000575	0.00351	CcSEcCtD
Pentobarbital—Shock—Prednisone—multiple sclerosis	0.000568	0.00346	CcSEcCtD
Pentobarbital—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000546	0.00333	CcSEcCtD
Pentobarbital—Feeling abnormal—Betamethasone—multiple sclerosis	0.000546	0.00333	CcSEcCtD
Pentobarbital—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000538	0.00328	CcSEcCtD
Pentobarbital—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000537	0.00328	CcSEcCtD
Pentobarbital—Dizziness—Prednisolone—multiple sclerosis	0.000525	0.0032	CcSEcCtD
Pentobarbital—Body temperature increased—Betamethasone—multiple sclerosis	0.000524	0.0032	CcSEcCtD
Pentobarbital—Body temperature increased—Dexamethasone—multiple sclerosis	0.000524	0.0032	CcSEcCtD
Pentobarbital—Rash—Prednisolone—multiple sclerosis	0.000501	0.00306	CcSEcCtD
Pentobarbital—Dermatitis—Prednisolone—multiple sclerosis	0.0005	0.00305	CcSEcCtD
Pentobarbital—Headache—Prednisolone—multiple sclerosis	0.000497	0.00304	CcSEcCtD
Pentobarbital—Constipation—Prednisone—multiple sclerosis	0.000493	0.00301	CcSEcCtD
Pentobarbital—Confusional state—Methotrexate—multiple sclerosis	0.000486	0.00297	CcSEcCtD
Pentobarbital—Dizziness—Triamcinolone—multiple sclerosis	0.000483	0.00295	CcSEcCtD
Pentobarbital—Dizziness—Methylprednisolone—multiple sclerosis	0.000482	0.00294	CcSEcCtD
Pentobarbital—GRIA2—BDNF signaling pathway—KCNA3—multiple sclerosis	0.000479	0.023	CbGpPWpGaD
Pentobarbital—Feeling abnormal—Prednisone—multiple sclerosis	0.000476	0.0029	CcSEcCtD
Pentobarbital—Nausea—Prednisolone—multiple sclerosis	0.000472	0.00288	CcSEcCtD
Pentobarbital—Vomiting—Triamcinolone—multiple sclerosis	0.000464	0.00283	CcSEcCtD
Pentobarbital—Vomiting—Methylprednisolone—multiple sclerosis	0.000463	0.00283	CcSEcCtD
Pentobarbital—Rash—Triamcinolone—multiple sclerosis	0.00046	0.00281	CcSEcCtD
Pentobarbital—Dermatitis—Triamcinolone—multiple sclerosis	0.00046	0.00281	CcSEcCtD
Pentobarbital—Rash—Methylprednisolone—multiple sclerosis	0.000459	0.0028	CcSEcCtD
Pentobarbital—Dermatitis—Methylprednisolone—multiple sclerosis	0.000459	0.0028	CcSEcCtD
Pentobarbital—Headache—Triamcinolone—multiple sclerosis	0.000457	0.00279	CcSEcCtD
Pentobarbital—Headache—Methylprednisolone—multiple sclerosis	0.000456	0.00279	CcSEcCtD
Pentobarbital—Body temperature increased—Prednisone—multiple sclerosis	0.000456	0.00278	CcSEcCtD
Pentobarbital—Hypotension—Methotrexate—multiple sclerosis	0.000451	0.00275	CcSEcCtD
Pentobarbital—Dizziness—Dexamethasone—multiple sclerosis	0.000438	0.00267	CcSEcCtD
Pentobarbital—Dizziness—Betamethasone—multiple sclerosis	0.000438	0.00267	CcSEcCtD
Pentobarbital—Nausea—Triamcinolone—multiple sclerosis	0.000434	0.00265	CcSEcCtD
Pentobarbital—Nausea—Methylprednisolone—multiple sclerosis	0.000433	0.00264	CcSEcCtD
Pentobarbital—Somnolence—Methotrexate—multiple sclerosis	0.000429	0.00262	CcSEcCtD
Pentobarbital—Hypersensitivity—Prednisone—multiple sclerosis	0.000425	0.00259	CcSEcCtD
Pentobarbital—Vomiting—Betamethasone—multiple sclerosis	0.000421	0.00257	CcSEcCtD
Pentobarbital—Vomiting—Dexamethasone—multiple sclerosis	0.000421	0.00257	CcSEcCtD
Pentobarbital—Rash—Dexamethasone—multiple sclerosis	0.000418	0.00255	CcSEcCtD
Pentobarbital—Rash—Betamethasone—multiple sclerosis	0.000418	0.00255	CcSEcCtD
Pentobarbital—Dermatitis—Betamethasone—multiple sclerosis	0.000417	0.00255	CcSEcCtD
Pentobarbital—Dermatitis—Dexamethasone—multiple sclerosis	0.000417	0.00255	CcSEcCtD
Pentobarbital—Headache—Betamethasone—multiple sclerosis	0.000415	0.00253	CcSEcCtD
Pentobarbital—Headache—Dexamethasone—multiple sclerosis	0.000415	0.00253	CcSEcCtD
Pentobarbital—Feeling abnormal—Methotrexate—multiple sclerosis	0.000397	0.00243	CcSEcCtD
Pentobarbital—Nausea—Betamethasone—multiple sclerosis	0.000394	0.0024	CcSEcCtD
Pentobarbital—Nausea—Dexamethasone—multiple sclerosis	0.000394	0.0024	CcSEcCtD
Pentobarbital—GRIA2—N-cadherin signaling events—CNR1—multiple sclerosis	0.000386	0.0185	CbGpPWpGaD
Pentobarbital—CYP2A6—Fluoropyrimidine Activity—RRM1—multiple sclerosis	0.000385	0.0185	CbGpPWpGaD
Pentobarbital—GRIA2—BDNF signaling pathway—LINGO1—multiple sclerosis	0.000383	0.0184	CbGpPWpGaD
Pentobarbital—Dizziness—Prednisone—multiple sclerosis	0.000382	0.00233	CcSEcCtD
Pentobarbital—Body temperature increased—Methotrexate—multiple sclerosis	0.000381	0.00233	CcSEcCtD
Pentobarbital—GRIK2—Neuronal System—KCNA3—multiple sclerosis	0.000369	0.0177	CbGpPWpGaD
Pentobarbital—Vomiting—Prednisone—multiple sclerosis	0.000367	0.00224	CcSEcCtD
Pentobarbital—Rash—Prednisone—multiple sclerosis	0.000364	0.00222	CcSEcCtD
Pentobarbital—Dermatitis—Prednisone—multiple sclerosis	0.000363	0.00222	CcSEcCtD
Pentobarbital—Headache—Prednisone—multiple sclerosis	0.000361	0.00221	CcSEcCtD
Pentobarbital—GABRA1—SIDS Susceptibility Pathways—PLP1—multiple sclerosis	0.000356	0.0171	CbGpPWpGaD
Pentobarbital—Hypersensitivity—Methotrexate—multiple sclerosis	0.000355	0.00217	CcSEcCtD
Pentobarbital—Nausea—Prednisone—multiple sclerosis	0.000343	0.00209	CcSEcCtD
Pentobarbital—CHRNA7—Neuronal System—KCNA3—multiple sclerosis	0.000336	0.0161	CbGpPWpGaD
Pentobarbital—GABRB3—BDNF signaling pathway—KCNA3—multiple sclerosis	0.000335	0.0161	CbGpPWpGaD
Pentobarbital—Dizziness—Methotrexate—multiple sclerosis	0.000319	0.00195	CcSEcCtD
Pentobarbital—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000315	0.0151	CbGpPWpGaD
Pentobarbital—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000315	0.0151	CbGpPWpGaD
Pentobarbital—CYP2A6—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000311	0.0149	CbGpPWpGaD
Pentobarbital—CYP2A6—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000311	0.0149	CbGpPWpGaD
Pentobarbital—Vomiting—Methotrexate—multiple sclerosis	0.000307	0.00187	CcSEcCtD
Pentobarbital—Rash—Methotrexate—multiple sclerosis	0.000304	0.00186	CcSEcCtD
Pentobarbital—Dermatitis—Methotrexate—multiple sclerosis	0.000304	0.00185	CcSEcCtD
Pentobarbital—Headache—Methotrexate—multiple sclerosis	0.000302	0.00184	CcSEcCtD
Pentobarbital—CHRNA7—SIDS Susceptibility Pathways—C4A—multiple sclerosis	0.000293	0.014	CbGpPWpGaD
Pentobarbital—Nausea—Methotrexate—multiple sclerosis	0.000286	0.00175	CcSEcCtD
Pentobarbital—GRIA2—Neuronal System—KCNA3—multiple sclerosis	0.000282	0.0135	CbGpPWpGaD
Pentobarbital—CHRNA4—Neuronal System—KCNA3—multiple sclerosis	0.000274	0.0131	CbGpPWpGaD
Pentobarbital—GABRB3—BDNF signaling pathway—LINGO1—multiple sclerosis	0.000268	0.0128	CbGpPWpGaD
Pentobarbital—CYP2A6—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000255	0.0122	CbGpPWpGaD
Pentobarbital—CYP2A6—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000255	0.0122	CbGpPWpGaD
Pentobarbital—CHRNA4—SIDS Susceptibility Pathways—C4A—multiple sclerosis	0.000239	0.0115	CbGpPWpGaD
Pentobarbital—GABRA6—Neuronal System—KCNA3—multiple sclerosis	0.000235	0.0113	CbGpPWpGaD
Pentobarbital—GABRA4—Neuronal System—KCNA3—multiple sclerosis	0.000232	0.0111	CbGpPWpGaD
Pentobarbital—CHRNA7—SIDS Susceptibility Pathways—AQP4—multiple sclerosis	0.000222	0.0106	CbGpPWpGaD
Pentobarbital—GABRB2—Neuronal System—KCNA3—multiple sclerosis	0.000212	0.0102	CbGpPWpGaD
Pentobarbital—GABRA5—Neuronal System—KCNA3—multiple sclerosis	0.000206	0.00988	CbGpPWpGaD
Pentobarbital—GABRA3—Neuronal System—KCNA3—multiple sclerosis	0.000202	0.0097	CbGpPWpGaD
Pentobarbital—GABRA2—Neuronal System—KCNA3—multiple sclerosis	0.000199	0.00953	CbGpPWpGaD
Pentobarbital—GABRB3—Neuronal System—KCNA3—multiple sclerosis	0.000197	0.00947	CbGpPWpGaD
Pentobarbital—GABRG2—Neuronal System—KCNA3—multiple sclerosis	0.000194	0.0093	CbGpPWpGaD
Pentobarbital—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000192	0.0092	CbGpPWpGaD
Pentobarbital—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000192	0.0092	CbGpPWpGaD
Pentobarbital—CYP2C19—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000189	0.00908	CbGpPWpGaD
Pentobarbital—CYP2C19—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000189	0.00908	CbGpPWpGaD
Pentobarbital—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.000182	0.00872	CbGpPWpGaD
Pentobarbital—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.000182	0.00872	CbGpPWpGaD
Pentobarbital—CHRNA4—SIDS Susceptibility Pathways—AQP4—multiple sclerosis	0.000181	0.00868	CbGpPWpGaD
Pentobarbital—GABRA1—Neuronal System—KCNA3—multiple sclerosis	0.000169	0.00813	CbGpPWpGaD
Pentobarbital—CYP3A4—Irinotecan Pathway—BCHE—multiple sclerosis	0.000161	0.00772	CbGpPWpGaD
Pentobarbital—CYP2C19—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000156	0.00746	CbGpPWpGaD
Pentobarbital—CYP2C19—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000156	0.00746	CbGpPWpGaD
Pentobarbital—GABRA1—SIDS Susceptibility Pathways—C4A—multiple sclerosis	0.000148	0.00709	CbGpPWpGaD
Pentobarbital—CYP2A6—Biological oxidations—CYP27B1—multiple sclerosis	0.000136	0.0065	CbGpPWpGaD
Pentobarbital—CYP2A6—Biological oxidations—CYP24A1—multiple sclerosis	0.000136	0.0065	CbGpPWpGaD
Pentobarbital—GRIK2—Transmission across Chemical Synapses—BCHE—multiple sclerosis	0.000135	0.00648	CbGpPWpGaD
Pentobarbital—GRIA2—Hypothetical Network for Drug Addiction—MAPK1—multiple sclerosis	0.000131	0.00627	CbGpPWpGaD
Pentobarbital—GRIA2—BDNF signaling pathway—CNR1—multiple sclerosis	0.000127	0.0061	CbGpPWpGaD
Pentobarbital—CHRNA7—Transmission across Chemical Synapses—BCHE—multiple sclerosis	0.000123	0.00589	CbGpPWpGaD
Pentobarbital—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000115	0.00553	CbGpPWpGaD
Pentobarbital—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000115	0.00553	CbGpPWpGaD
Pentobarbital—CHRNA7—SIDS Susceptibility Pathways—BDNF—multiple sclerosis	0.000115	0.00551	CbGpPWpGaD
Pentobarbital—CYP3A4—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000114	0.00546	CbGpPWpGaD
Pentobarbital—CYP3A4—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000114	0.00546	CbGpPWpGaD
Pentobarbital—GABRA1—SIDS Susceptibility Pathways—AQP4—multiple sclerosis	0.000112	0.00537	CbGpPWpGaD
Pentobarbital—CHRNA7—SIDS Susceptibility Pathways—IL10—multiple sclerosis	0.00011	0.00526	CbGpPWpGaD
Pentobarbital—GRIA2—Activation of NMDA receptor upon glutamate binding and postsynaptic events—MAPK1—multiple sclerosis	0.000107	0.00514	CbGpPWpGaD
Pentobarbital—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	0.000104	0.00497	CbGpPWpGaD
Pentobarbital—GRIK2—Neuronal System—BCHE—multiple sclerosis	0.000104	0.00496	CbGpPWpGaD
Pentobarbital—GRIA2—Transmission across Chemical Synapses—BCHE—multiple sclerosis	0.000103	0.00495	CbGpPWpGaD
Pentobarbital—GRIA2—BDNF signaling pathway—BDNF—multiple sclerosis	0.000103	0.00494	CbGpPWpGaD
Pentobarbital—CHRNA4—Transmission across Chemical Synapses—BCHE—multiple sclerosis	0.0001	0.00481	CbGpPWpGaD
Pentobarbital—CHRNA7—Neuronal System—BCHE—multiple sclerosis	9.42e-05	0.00452	CbGpPWpGaD
Pentobarbital—CHRNA4—SIDS Susceptibility Pathways—BDNF—multiple sclerosis	9.36e-05	0.00449	CbGpPWpGaD
Pentobarbital—CYP3A4—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	9.36e-05	0.00449	CbGpPWpGaD
Pentobarbital—CYP3A4—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	9.36e-05	0.00449	CbGpPWpGaD
Pentobarbital—GRIA2—BDNF signaling pathway—SPP1—multiple sclerosis	9.13e-05	0.00438	CbGpPWpGaD
Pentobarbital—CYP2C19—Melatonin metabolism and effects—APOE—multiple sclerosis	8.99e-05	0.00431	CbGpPWpGaD
Pentobarbital—CHRNA4—SIDS Susceptibility Pathways—IL10—multiple sclerosis	8.94e-05	0.00429	CbGpPWpGaD
Pentobarbital—GABRB3—BDNF signaling pathway—CNR1—multiple sclerosis	8.9e-05	0.00427	CbGpPWpGaD
Pentobarbital—GABRA6—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	8.75e-05	0.00419	CbGpPWpGaD
Pentobarbital—GABRA4—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	8.64e-05	0.00414	CbGpPWpGaD
Pentobarbital—GABRA6—Transmission across Chemical Synapses—BCHE—multiple sclerosis	8.59e-05	0.00412	CbGpPWpGaD
Pentobarbital—GABRA4—Transmission across Chemical Synapses—BCHE—multiple sclerosis	8.49e-05	0.00407	CbGpPWpGaD
Pentobarbital—CYP2C19—Biological oxidations—CYP24A1—multiple sclerosis	8.26e-05	0.00396	CbGpPWpGaD
Pentobarbital—CYP2C19—Biological oxidations—CYP27B1—multiple sclerosis	8.26e-05	0.00396	CbGpPWpGaD
Pentobarbital—CYP2C19—Metapathway biotransformation—CYP24A1—multiple sclerosis	8.15e-05	0.00391	CbGpPWpGaD
Pentobarbital—CYP2C19—Metapathway biotransformation—CYP27B1—multiple sclerosis	8.15e-05	0.00391	CbGpPWpGaD
Pentobarbital—GRIA2—Neuronal System—BCHE—multiple sclerosis	7.92e-05	0.0038	CbGpPWpGaD
Pentobarbital—GABRB2—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	7.9e-05	0.00379	CbGpPWpGaD
Pentobarbital—GABRB2—Transmission across Chemical Synapses—BCHE—multiple sclerosis	7.76e-05	0.00372	CbGpPWpGaD
Pentobarbital—CHRNA4—Neuronal System—BCHE—multiple sclerosis	7.68e-05	0.00368	CbGpPWpGaD
Pentobarbital—GABRA5—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	7.68e-05	0.00368	CbGpPWpGaD
Pentobarbital—GABRA5—Transmission across Chemical Synapses—BCHE—multiple sclerosis	7.54e-05	0.00362	CbGpPWpGaD
Pentobarbital—GABRA3—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	7.54e-05	0.00361	CbGpPWpGaD
Pentobarbital—GABRA2—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	7.41e-05	0.00355	CbGpPWpGaD
Pentobarbital—GABRA3—Transmission across Chemical Synapses—BCHE—multiple sclerosis	7.4e-05	0.00355	CbGpPWpGaD
Pentobarbital—GABRB3—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	7.36e-05	0.00353	CbGpPWpGaD
Pentobarbital—GABRA2—Transmission across Chemical Synapses—BCHE—multiple sclerosis	7.28e-05	0.00349	CbGpPWpGaD
Pentobarbital—GABRB3—Transmission across Chemical Synapses—BCHE—multiple sclerosis	7.23e-05	0.00347	CbGpPWpGaD
Pentobarbital—GABRG2—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	7.23e-05	0.00346	CbGpPWpGaD
Pentobarbital—GABRB3—BDNF signaling pathway—BDNF—multiple sclerosis	7.2e-05	0.00345	CbGpPWpGaD
Pentobarbital—GABRG2—Transmission across Chemical Synapses—BCHE—multiple sclerosis	7.1e-05	0.0034	CbGpPWpGaD
Pentobarbital—CYP2A6—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	7.08e-05	0.0034	CbGpPWpGaD
Pentobarbital—GABRA6—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	6.63e-05	0.00318	CbGpPWpGaD
Pentobarbital—GABRA6—Neuronal System—BCHE—multiple sclerosis	6.58e-05	0.00316	CbGpPWpGaD
Pentobarbital—GABRA4—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	6.55e-05	0.00314	CbGpPWpGaD
Pentobarbital—GABRA4—Neuronal System—BCHE—multiple sclerosis	6.5e-05	0.00312	CbGpPWpGaD
Pentobarbital—GABRB3—BDNF signaling pathway—SPP1—multiple sclerosis	6.39e-05	0.00306	CbGpPWpGaD
Pentobarbital—GABRA1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	6.32e-05	0.00303	CbGpPWpGaD
Pentobarbital—GABRA1—Transmission across Chemical Synapses—BCHE—multiple sclerosis	6.2e-05	0.00297	CbGpPWpGaD
Pentobarbital—GABRB2—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	5.99e-05	0.00287	CbGpPWpGaD
Pentobarbital—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	5.95e-05	0.00285	CbGpPWpGaD
Pentobarbital—GABRB2—Neuronal System—BCHE—multiple sclerosis	5.95e-05	0.00285	CbGpPWpGaD
Pentobarbital—GABRA5—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	5.82e-05	0.00279	CbGpPWpGaD
Pentobarbital—GABRA1—SIDS Susceptibility Pathways—BDNF—multiple sclerosis	5.8e-05	0.00278	CbGpPWpGaD
Pentobarbital—GABRA5—Neuronal System—BCHE—multiple sclerosis	5.78e-05	0.00277	CbGpPWpGaD
Pentobarbital—CHRNA7—SIDS Susceptibility Pathways—IL1B—multiple sclerosis	5.75e-05	0.00276	CbGpPWpGaD
Pentobarbital—CYP2A6—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	5.74e-05	0.00275	CbGpPWpGaD
Pentobarbital—GABRA3—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	5.71e-05	0.00274	CbGpPWpGaD
Pentobarbital—GABRA3—Neuronal System—BCHE—multiple sclerosis	5.67e-05	0.00272	CbGpPWpGaD
Pentobarbital—GABRA2—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	5.61e-05	0.00269	CbGpPWpGaD
Pentobarbital—GABRB3—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	5.58e-05	0.00267	CbGpPWpGaD
Pentobarbital—GABRA2—Neuronal System—BCHE—multiple sclerosis	5.57e-05	0.00267	CbGpPWpGaD
Pentobarbital—GABRB3—Neuronal System—BCHE—multiple sclerosis	5.54e-05	0.00266	CbGpPWpGaD
Pentobarbital—GABRA1—SIDS Susceptibility Pathways—IL10—multiple sclerosis	5.53e-05	0.00265	CbGpPWpGaD
Pentobarbital—GABRG2—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	5.48e-05	0.00263	CbGpPWpGaD
Pentobarbital—GABRG2—Neuronal System—BCHE—multiple sclerosis	5.44e-05	0.00261	CbGpPWpGaD
Pentobarbital—GRIK2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	5.25e-05	0.00252	CbGpPWpGaD
Pentobarbital—GABRA6—Transmembrane transport of small molecules—AQP4—multiple sclerosis	5.24e-05	0.00251	CbGpPWpGaD
Pentobarbital—GABRA4—Transmembrane transport of small molecules—AQP4—multiple sclerosis	5.17e-05	0.00248	CbGpPWpGaD
Pentobarbital—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	4.97e-05	0.00238	CbGpPWpGaD
Pentobarbital—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	4.97e-05	0.00238	CbGpPWpGaD
Pentobarbital—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	4.9e-05	0.00235	CbGpPWpGaD
Pentobarbital—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	4.9e-05	0.00235	CbGpPWpGaD
Pentobarbital—GABRA1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	4.79e-05	0.0023	CbGpPWpGaD
Pentobarbital—CHRNA7—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	4.78e-05	0.00229	CbGpPWpGaD
Pentobarbital—GABRA1—Neuronal System—BCHE—multiple sclerosis	4.75e-05	0.00228	CbGpPWpGaD
Pentobarbital—GABRB2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	4.73e-05	0.00227	CbGpPWpGaD
Pentobarbital—CHRNA4—SIDS Susceptibility Pathways—IL1B—multiple sclerosis	4.69e-05	0.00225	CbGpPWpGaD
Pentobarbital—GABRA6—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	4.63e-05	0.00222	CbGpPWpGaD
Pentobarbital—GABRA5—Transmembrane transport of small molecules—AQP4—multiple sclerosis	4.6e-05	0.0022	CbGpPWpGaD
Pentobarbital—GABRA4—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	4.57e-05	0.00219	CbGpPWpGaD
Pentobarbital—GABRA3—Transmembrane transport of small molecules—AQP4—multiple sclerosis	4.52e-05	0.00217	CbGpPWpGaD
Pentobarbital—GABRA2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	4.44e-05	0.00213	CbGpPWpGaD
Pentobarbital—GABRB3—Transmembrane transport of small molecules—AQP4—multiple sclerosis	4.41e-05	0.00211	CbGpPWpGaD
Pentobarbital—GABRG2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	4.33e-05	0.00208	CbGpPWpGaD
Pentobarbital—GRIA2—BDNF signaling pathway—STAT3—multiple sclerosis	4.32e-05	0.00207	CbGpPWpGaD
Pentobarbital—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	4.32e-05	0.00207	CbGpPWpGaD
Pentobarbital—GABRB2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	4.18e-05	0.00201	CbGpPWpGaD
Pentobarbital—CHRNA7—SIDS Susceptibility Pathways—TNF—multiple sclerosis	4.17e-05	0.002	CbGpPWpGaD
Pentobarbital—GABRA5—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	4.06e-05	0.00195	CbGpPWpGaD
Pentobarbital—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	4.02e-05	0.00193	CbGpPWpGaD
Pentobarbital—GABRA3—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	3.99e-05	0.00191	CbGpPWpGaD
Pentobarbital—GRIK2—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	3.95e-05	0.00189	CbGpPWpGaD
Pentobarbital—GRIA2—BDNF signaling pathway—MAPK1—multiple sclerosis	3.93e-05	0.00188	CbGpPWpGaD
Pentobarbital—GABRA2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	3.92e-05	0.00188	CbGpPWpGaD
Pentobarbital—GABRB3—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	3.9e-05	0.00187	CbGpPWpGaD
Pentobarbital—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	3.9e-05	0.00187	CbGpPWpGaD
Pentobarbital—GABRG2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	3.83e-05	0.00183	CbGpPWpGaD
Pentobarbital—GABRA1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	3.78e-05	0.00181	CbGpPWpGaD
Pentobarbital—CHRNA7—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	3.59e-05	0.00172	CbGpPWpGaD
Pentobarbital—CYP2C19—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	3.5e-05	0.00168	CbGpPWpGaD
Pentobarbital—CHRNA4—SIDS Susceptibility Pathways—TNF—multiple sclerosis	3.4e-05	0.00163	CbGpPWpGaD
Pentobarbital—CHRNA7—SIDS Susceptibility Pathways—IL6—multiple sclerosis	3.37e-05	0.00161	CbGpPWpGaD
Pentobarbital—GABRA1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	3.34e-05	0.0016	CbGpPWpGaD
Pentobarbital—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	3.34e-05	0.0016	CbGpPWpGaD
Pentobarbital—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	3.3e-05	0.00158	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—SRM—multiple sclerosis	3.29e-05	0.00158	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	3.17e-05	0.00152	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	3.17e-05	0.00152	CbGpPWpGaD
Pentobarbital—CYP2A6—Biological oxidations—POMC—multiple sclerosis	3.05e-05	0.00146	CbGpPWpGaD
Pentobarbital—GRIK2—Neuronal System—MAPK1—multiple sclerosis	3.03e-05	0.00145	CbGpPWpGaD
Pentobarbital—GABRB3—BDNF signaling pathway—STAT3—multiple sclerosis	3.02e-05	0.00145	CbGpPWpGaD
Pentobarbital—GRIA2—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	3.02e-05	0.00145	CbGpPWpGaD
Pentobarbital—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	3.02e-05	0.00145	CbGpPWpGaD
Pentobarbital—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	2.93e-05	0.00141	CbGpPWpGaD
Pentobarbital—CHRNA4—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	2.93e-05	0.0014	CbGpPWpGaD
Pentobarbital—GABRA1—SIDS Susceptibility Pathways—IL1B—multiple sclerosis	2.9e-05	0.00139	CbGpPWpGaD
Pentobarbital—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	2.88e-05	0.00138	CbGpPWpGaD
Pentobarbital—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	2.83e-05	0.00136	CbGpPWpGaD
Pentobarbital—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	2.81e-05	0.00135	CbGpPWpGaD
Pentobarbital—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	2.76e-05	0.00132	CbGpPWpGaD
Pentobarbital—CHRNA7—Neuronal System—MAPK1—multiple sclerosis	2.75e-05	0.00132	CbGpPWpGaD
Pentobarbital—GABRB3—BDNF signaling pathway—MAPK1—multiple sclerosis	2.75e-05	0.00132	CbGpPWpGaD
Pentobarbital—CHRNA4—SIDS Susceptibility Pathways—IL6—multiple sclerosis	2.75e-05	0.00132	CbGpPWpGaD
Pentobarbital—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	2.6e-05	0.00124	CbGpPWpGaD
Pentobarbital—GABRA6—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	2.51e-05	0.0012	CbGpPWpGaD
Pentobarbital—GABRA4—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	2.48e-05	0.00119	CbGpPWpGaD
Pentobarbital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	2.41e-05	0.00116	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—CYP27B1—multiple sclerosis	2.32e-05	0.00111	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—CYP24A1—multiple sclerosis	2.32e-05	0.00111	CbGpPWpGaD
Pentobarbital—GRIA2—Neuronal System—MAPK1—multiple sclerosis	2.31e-05	0.00111	CbGpPWpGaD
Pentobarbital—GABRB2—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	2.27e-05	0.00109	CbGpPWpGaD
Pentobarbital—CHRNA4—Neuronal System—MAPK1—multiple sclerosis	2.24e-05	0.00108	CbGpPWpGaD
Pentobarbital—GABRA5—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	2.2e-05	0.00106	CbGpPWpGaD
Pentobarbital—GABRA3—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	2.16e-05	0.00104	CbGpPWpGaD
Pentobarbital—GABRA2—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	2.13e-05	0.00102	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—GPC5—multiple sclerosis	2.12e-05	0.00102	CbGpPWpGaD
Pentobarbital—GABRB3—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	2.11e-05	0.00101	CbGpPWpGaD
Pentobarbital—GABRA1—SIDS Susceptibility Pathways—TNF—multiple sclerosis	2.11e-05	0.00101	CbGpPWpGaD
Pentobarbital—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	2.1e-05	0.00101	CbGpPWpGaD
Pentobarbital—GABRG2—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	2.07e-05	0.000995	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—SRM—multiple sclerosis	2.01e-05	0.000962	CbGpPWpGaD
Pentobarbital—CYP2A6—NRF2 pathway—TGFB1—multiple sclerosis	2e-05	0.000961	CbGpPWpGaD
Pentobarbital—GABRA6—Neuronal System—MAPK1—multiple sclerosis	1.92e-05	0.000923	CbGpPWpGaD
Pentobarbital—GABRA4—Neuronal System—MAPK1—multiple sclerosis	1.9e-05	0.000911	CbGpPWpGaD
Pentobarbital—CYP2C19—Biological oxidations—POMC—multiple sclerosis	1.86e-05	0.000891	CbGpPWpGaD
Pentobarbital—GABRA1—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	1.81e-05	0.000869	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—RRM1—multiple sclerosis	1.76e-05	0.000842	CbGpPWpGaD
Pentobarbital—GABRB2—Neuronal System—MAPK1—multiple sclerosis	1.74e-05	0.000833	CbGpPWpGaD
Pentobarbital—GABRA1—SIDS Susceptibility Pathways—IL6—multiple sclerosis	1.7e-05	0.000815	CbGpPWpGaD
Pentobarbital—GABRA5—Neuronal System—MAPK1—multiple sclerosis	1.69e-05	0.00081	CbGpPWpGaD
Pentobarbital—GABRA6—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.67e-05	0.0008	CbGpPWpGaD
Pentobarbital—GABRA3—Neuronal System—MAPK1—multiple sclerosis	1.66e-05	0.000795	CbGpPWpGaD
Pentobarbital—GABRA4—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.65e-05	0.00079	CbGpPWpGaD
Pentobarbital—GABRA2—Neuronal System—MAPK1—multiple sclerosis	1.63e-05	0.000781	CbGpPWpGaD
Pentobarbital—GABRB3—Neuronal System—MAPK1—multiple sclerosis	1.62e-05	0.000776	CbGpPWpGaD
Pentobarbital—GABRG2—Neuronal System—MAPK1—multiple sclerosis	1.59e-05	0.000762	CbGpPWpGaD
Pentobarbital—GABRB2—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.51e-05	0.000722	CbGpPWpGaD
Pentobarbital—GABRA5—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.46e-05	0.000702	CbGpPWpGaD
Pentobarbital—GABRA3—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.44e-05	0.000689	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—CYP27B1—multiple sclerosis	1.41e-05	0.000678	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—CYP24A1—multiple sclerosis	1.41e-05	0.000678	CbGpPWpGaD
Pentobarbital—GABRA2—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.41e-05	0.000677	CbGpPWpGaD
Pentobarbital—GABRB3—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.4e-05	0.000673	CbGpPWpGaD
Pentobarbital—GABRA1—Neuronal System—MAPK1—multiple sclerosis	1.39e-05	0.000666	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.38e-05	0.000662	CbGpPWpGaD
Pentobarbital—GABRG2—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.38e-05	0.000661	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—GPC5—multiple sclerosis	1.29e-05	0.00062	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—SRM—multiple sclerosis	1.21e-05	0.000578	CbGpPWpGaD
Pentobarbital—GABRA1—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.2e-05	0.000577	CbGpPWpGaD
Pentobarbital—CYP3A4—Biological oxidations—POMC—multiple sclerosis	1.12e-05	0.000536	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—RRM1—multiple sclerosis	1.07e-05	0.000514	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—BCHE—multiple sclerosis	1.01e-05	0.000484	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	8.5e-06	0.000408	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	8.5e-06	0.000408	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	8.31e-06	0.000398	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—GPC5—multiple sclerosis	7.77e-06	0.000373	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	7.14e-06	0.000342	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	6.51e-06	0.000312	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—RRM1—multiple sclerosis	6.44e-06	0.000309	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—BCHE—multiple sclerosis	6.15e-06	0.000295	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—APOE—multiple sclerosis	6.07e-06	0.000291	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—POMC—multiple sclerosis	5.21e-06	0.00025	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—ALB—multiple sclerosis	4.75e-06	0.000228	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—APOE—multiple sclerosis	3.7e-06	0.000177	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—BCHE—multiple sclerosis	3.7e-06	0.000177	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—POMC—multiple sclerosis	3.18e-06	0.000152	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—ALB—multiple sclerosis	2.9e-06	0.000139	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—APOE—multiple sclerosis	2.23e-06	0.000107	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—POMC—multiple sclerosis	1.91e-06	9.17e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—ALB—multiple sclerosis	1.74e-06	8.36e-05	CbGpPWpGaD
